I.M. Sechenov First Moscow State Medical University (Sechenov University)
Moscow, Russia
NCT Number: NCT04474639
It is a prospective, controlled, single-center, non-randomized, observational study.
From September 2019 to December 2020, the study plans to prospectively include 400 patients aged 18 to 90 years.
Every patients will undergo an echocardiographic examination with assessment diastolic dysfunction of the left ventricle, and registration of an electrocardiogram using a single lead ECG monitor CardioQvark (in I standard lead) for 3 minutes. All patients will be divided into 2 main groups: with diastolic dysfunction of the left ventricle, confirmed by the results of the echocardiography and without. A spectral analysis of the electrocardiogram will be performed using a continuous wavelet transform.
The result of this study will be the identification of ECG parameters that will correlate with LV diastolic dysfunction.
Looking for future studies?
Notify Me18 year–90 year
All sexes
Observational
Moscow, Russia
It is a prospective, controlled, single-center, non-randomized, observational study.
From September 2019 to December 2020, the study plans to prospectively include 400 patients aged 18 to 90 years.
The goal of study is reveal single parameters of the electrocardiogram, which a good correlation with left ventricular diastolic dysfunction (LV DD), discovered during echocardiography.
Investigators plan to assess the diagnostic effectiveness of the spectral analysis of electrocardiograms obtained using a single-lead portable ECG monitor.
All subjects will undergo an echocardiographic examination of the heart with a determination of diastolic dysfunction of the left ventricle and will be divided into 2 main groups: with diastolic dysfunction of the left ventricle, confirmed by the results of the echocardiography and without.
At the same time, for all patients single-lead ECG will be recorded (in turn of leads I) for 3 minutes with further spectral analysis of the data obtained.
A single-lead ECG monitor CardioQvark is designed as an iPhone cover. It is registered with the Federal Service for Health Supervision on February 15, 2019. RZN No. 2019/8124.
Then a spectral analysis of the electrocardiogram will be performed using a continuous wavelet transform, the principles of which are based on the Fourier transform.
The analysis implies an assessment of the following parameters (the parameters listed below will be calculated as the median of the tact-cycle):
Additionally used parameters:
Statistical processing of results: SPSS Statistics Version 26 is a computer program for statistical processing of data.
The result of this study will be the identification of ECG parameters that will correlate with LV diastolic dysfunction, and by which it will be possible to determine its presence and degree in the future.
Investigators also plan to analyze ECG parameters characteristic of patients with LV diastolic dysfunction in different population groups:
During statistical processing of the data, the following will be calculated: sensitivity, specificity, prognostic value of positive and negative results, likelihood ratio, area under ROC - curve, correlation coefficient. it is planned to obtain data on the diagnostic effectiveness of the proposed approach, as well as on individual parameters of the electrocardiogram in the diagnosis of diastolic dysfunction of the left ventricle.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Non-inclusion criteria:
conducting an echocardiographic study according to a standard protocol with the determination of diastolic dysfunction of the left ventricle
Time frame: through study completion, an average of 2 years
comparison of the presence of LV DD detected by the results of an echocardiographic study with the results of the presence of LV DD obtained using the mathematical model of a single-channel ECG of the CardioQvark monitor
Time frame: through study completion, an average of 2 years
comparison of the presence of LV DD detected by the results of an echocardiographic study with the results of the presence of LV DD obtained using the mathematical model of a single-channel ECG of the CardioQvark monitor
Time frame: through study completion, an average of 2 years
comparison of the presence of LV DD detected by the results of an echocardiographic study with the results of the presence of LV DD obtained using the mathematical model of a single-channel ECG of the CardioQvark monitor
Time frame: through study completion, an average of 2 years
comparison of the presence of LV DD detected by the results of an echocardiographic study with the results of the presence of LV DD obtained using the mathematical model of a single-channel ECG of the CardioQvark monitor
Time frame: through study completion, an average of 2 years
comparison of the presence of LV DD detected by the results of an echocardiographic study with the results of the presence of LV DD obtained using the mathematical model of a single-channel ECG of the CardioQvark monitor
Time frame: through study completion, an average of 2 years
comparison of the presence of LV DD detected by the results of an echocardiographic study with the results of the presence of LV DD obtained using the mathematical model of a single-channel ECG of the CardioQvark monitor
Time frame: through study completion, an average of 2 years
an ECG spectral analysis will be performed using the Fourier Transform
Time frame: through study completion, an average of 2 years
an ECG spectral analysis will be performed using the Fourier Transform
Time frame: through study completion, an average of 2 years
an ECG spectral analysis will be performed using the Fourier Transform
Time frame: through study completion, an average of 2 years
an ECG spectral analysis will be performed using the Fourier Transform
Time frame: through study completion, an average of 2 years
an ECG spectral analysis will be performed using the Fourier Transform
Time frame: through study completion, an average of 2 years
an ECG spectral analysis will be performed using the Fourier Transform
Time frame: through study completion, an average of 2 years
an ECG spectral analysis will be performed using the Fourier Transform
Time frame: through study completion, an average of 2 years
an ECG spectral analysis will be performed using the Fourier Transform
Time frame: through study completion, an average of 2 years
an ECG spectral analysis will be performed using the Fourier Transform
Time frame: through study completion, an average of 2 years
an ECG spectral analysis will be performed using the Fourier Transform
Time frame: through study completion, an average of 2 years
an ECG spectral analysis will be performed using the Fourier Transform
Time frame: through study completion, an average of 2 years
an ECG spectral analysis will be performed using the Fourier Transform
Time frame: through study completion, an average of 2 years
an ECG spectral analysis will be performed using the Fourier Transform
Time frame: through study completion, an average of 2 years
an ECG spectral analysis will be performed using the Fourier Transform
Time frame: through study completion, an average of 2 years
an ECG spectral analysis will be performed using the Fourier Transform
Time frame: through study completion, an average of 2 years
an ECG spectral analysis will be performed using the Fourier Transform
I.M. Sechenov First Moscow State Medical University
Other
Diastolic Dysfunction Assessment of the Left Ventricle Using Spectral Analysis of a Single Lead ECG
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05726474
Arterial Stiffness, Behavior
Cuenca, Spain
View Trial DetailsNCT02097784
Acute Kidney Injury, Cirrhosis
Lyon, France
View Trial DetailsNCT04068233
AV Block, Arrhythmias, Cardiac
Linz, Upper Austria, Austria
View Trial DetailsNCT02138903
Critical Care, Diastolic Function
Clermont-Ferrand, France
View Trial Details